Swedish private equity firm sets up biotech fund

Swedish private equity firm Innoventus has unveiled its first product to invest in biotechnology.

The Innoventus Life Science fund is hoping to raise Skr600m (€65.7m) within 12 months, said Hans Andréasson, managing director of Innoventus. The fund has already secured 50% of its capital from Swedish institutions such as A-P Fonden 4 and 6.

WSJ Logo
Jamie Dimon Says Private Credit Is Dangerous—and He Wants JPMorgan to Get In on ItExternal link

Jamie Dimon Says Private Credit Is Dangerous—and He Wants JPMorgan to Get In on It